Characterization and genomic localization of a SMAD4 processed pseudogene

Like many clinical diagnostic laboratories, the Yorkshire Regional Genetics Service undertakes routine investigation of cancer-predisposed individuals by high-throughput sequencing of patient DNA that has been target-enriched for genes associated with hereditary cancer. Accurate diagnosis using such...

Full description

Bibliographic Details
Main Authors: Watson, CM, Camm, N, Crinnion, LA, Antanaviciute, A, Adlard, J, Markham, AF, Carr, IM, Charlton, R, Bonthron, DT
Format: Journal article
Language:English
Published: Elsevier 2017
_version_ 1826312347062370304
author Watson, CM
Camm, N
Crinnion, LA
Antanaviciute, A
Adlard, J
Markham, AF
Carr, IM
Charlton, R
Bonthron, DT
author_facet Watson, CM
Camm, N
Crinnion, LA
Antanaviciute, A
Adlard, J
Markham, AF
Carr, IM
Charlton, R
Bonthron, DT
author_sort Watson, CM
collection OXFORD
description Like many clinical diagnostic laboratories, the Yorkshire Regional Genetics Service undertakes routine investigation of cancer-predisposed individuals by high-throughput sequencing of patient DNA that has been target-enriched for genes associated with hereditary cancer. Accurate diagnosis using such reagents requires alertness regarding rare nonpathogenic variants that may interfere with variant calling. In a cohort of 2042 such cases, we identified 5 that initially appeared to be carriers of a 95-bp deletion of SMAD4 intron 6. More detailed analysis indicated that these individuals all carried one copy of a SMAD4 processed gene. Because of its interference with diagnostic analysis, we characterized this processed gene in detail. Whole-genome sequencing and confirmatory Sanger sequencing of junction PCR products were used to show that in each of the 5 cases, the SMAD4 processed gene was integrated at the same position on chromosome 9, located within the last intron of the SCAI gene. This rare polymorphic processed gene therefore reflects the occurrence of a single ancestral retrotransposition event. Compared to the reference SMAD4 mRNA sequence NM_005359.5 (https://www.ncbi.nlm.nih.gov/nucleotide), the 5' and 3' untranslated regions of the processed gene are both truncated, but its open reading frame is unaltered. Our experience leads us to advocate the use of an RNA-seq aligner as part of diagnostic assay quality assurance, since this allows recognition of processed pseudogenes in a comparatively facile automated fashion.
first_indexed 2024-03-07T08:27:39Z
format Journal article
id oxford-uuid:70829e5f-409c-4148-9452-bc4408f3429c
institution University of Oxford
language English
last_indexed 2024-03-07T08:27:39Z
publishDate 2017
publisher Elsevier
record_format dspace
spelling oxford-uuid:70829e5f-409c-4148-9452-bc4408f3429c2024-02-23T10:22:26ZCharacterization and genomic localization of a SMAD4 processed pseudogeneJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:70829e5f-409c-4148-9452-bc4408f3429cEnglishSymplectic Elements at OxfordElsevier2017Watson, CMCamm, NCrinnion, LAAntanaviciute, AAdlard, JMarkham, AFCarr, IMCharlton, RBonthron, DTLike many clinical diagnostic laboratories, the Yorkshire Regional Genetics Service undertakes routine investigation of cancer-predisposed individuals by high-throughput sequencing of patient DNA that has been target-enriched for genes associated with hereditary cancer. Accurate diagnosis using such reagents requires alertness regarding rare nonpathogenic variants that may interfere with variant calling. In a cohort of 2042 such cases, we identified 5 that initially appeared to be carriers of a 95-bp deletion of SMAD4 intron 6. More detailed analysis indicated that these individuals all carried one copy of a SMAD4 processed gene. Because of its interference with diagnostic analysis, we characterized this processed gene in detail. Whole-genome sequencing and confirmatory Sanger sequencing of junction PCR products were used to show that in each of the 5 cases, the SMAD4 processed gene was integrated at the same position on chromosome 9, located within the last intron of the SCAI gene. This rare polymorphic processed gene therefore reflects the occurrence of a single ancestral retrotransposition event. Compared to the reference SMAD4 mRNA sequence NM_005359.5 (https://www.ncbi.nlm.nih.gov/nucleotide), the 5' and 3' untranslated regions of the processed gene are both truncated, but its open reading frame is unaltered. Our experience leads us to advocate the use of an RNA-seq aligner as part of diagnostic assay quality assurance, since this allows recognition of processed pseudogenes in a comparatively facile automated fashion.
spellingShingle Watson, CM
Camm, N
Crinnion, LA
Antanaviciute, A
Adlard, J
Markham, AF
Carr, IM
Charlton, R
Bonthron, DT
Characterization and genomic localization of a SMAD4 processed pseudogene
title Characterization and genomic localization of a SMAD4 processed pseudogene
title_full Characterization and genomic localization of a SMAD4 processed pseudogene
title_fullStr Characterization and genomic localization of a SMAD4 processed pseudogene
title_full_unstemmed Characterization and genomic localization of a SMAD4 processed pseudogene
title_short Characterization and genomic localization of a SMAD4 processed pseudogene
title_sort characterization and genomic localization of a smad4 processed pseudogene
work_keys_str_mv AT watsoncm characterizationandgenomiclocalizationofasmad4processedpseudogene
AT cammn characterizationandgenomiclocalizationofasmad4processedpseudogene
AT crinnionla characterizationandgenomiclocalizationofasmad4processedpseudogene
AT antanaviciutea characterizationandgenomiclocalizationofasmad4processedpseudogene
AT adlardj characterizationandgenomiclocalizationofasmad4processedpseudogene
AT markhamaf characterizationandgenomiclocalizationofasmad4processedpseudogene
AT carrim characterizationandgenomiclocalizationofasmad4processedpseudogene
AT charltonr characterizationandgenomiclocalizationofasmad4processedpseudogene
AT bonthrondt characterizationandgenomiclocalizationofasmad4processedpseudogene